Skip to content
Sandra Ortiz-Cuaran· @SandraOrtizCua1 · X·· 2026-04-19Score60
Body

Today at #AACR26, I will share new data on the molecular characterization of patient-derived models of #BRAF-mutant #NSCLC to study treatment-persistent residual disease.

If you’re around, stop by and take a look !

#BOLEROConsortium

@Luc_Friboulet

@dplanchard

@JulienMazieres

Heat 6 · 5 likes · 0 replies · 1 repost

Source: Sandra Ortiz-Cuaran · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org